You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

steroid refractory acute graft vs. host disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GVHD,Acute Trial (OSSM-001)

Withdrawn
  • GVHD,Acute
  • OSSM-001
  • (no location specified)
Dec 21, 2022

Steroid-refractory Acute Graft-versus-host Disease Trial (MC0518, BAT)

Not yet recruiting
  • Steroid-refractory Acute Graft-versus-host Disease
  • MC0518
  • BAT
  • (no location specified)
Oct 4, 2023

Steroid-refractory Acute Graft-versus-Host Disease, Treatment-refractory Acute Graft-versus-Host Disease Trial in United States

Completed
  • Steroid-refractory Acute Graft-versus-Host Disease
  • Treatment-refractory Acute Graft-versus-Host Disease
  • Neihulizumab (ALTB-168)
  • Duarte, California
  • +12 more
Jan 17, 2023

Hematopoietic and Lymphoid Cell Tumor, Steroid Refractory GVHD Trial in Houston (Cellular Therapy, Ruxolitinib)

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Steroid Refractory Graft Versus Host Disease
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022

Acute GVHD Trial in Kansas City (MSCTC-0010 Dose Escalation)

Recruiting
  • Acute Graft Versus Host Disease
  • MSCTC-0010 Dose Escalation
  • Kansas City, Kansas
    Kansas University Cancer Center
Jan 30, 2023

Steroid-Refractory Acute GVHD Trial in Worldwide (T-Guard, Ruxolitinib)

Terminated
  • Steroid-Refractory Acute Graft Versus Host Disease
  • Birmingham, Alabama
  • +47 more
Jan 22, 2023

Acute GVHD, Steroid Refractory GVHD Trial in Columbus (BRD4 Inhibitor PLX51107)

Recruiting
  • Acute Graft Versus Host Disease
  • Steroid Refractory Graft Versus Host Disease
  • BRD4 Inhibitor PLX51107
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 24, 2022

GVHD Trial in Cleveland (Allogeneic mesenchymal stromal cells (MSCs), Extracorporeal photopheresis (ECP))

Not yet recruiting
  • Graft Versus Host Disease
  • Allogeneic mesenchymal stromal cells (MSCs)
  • Extracorporeal photopheresis (ECP)
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Nov 14, 2022

Acute GVHD Trial in Zhengzhou (Jaktinib Hydrochloride Tablets)

Not yet recruiting
  • Acute Graft-Versus-Host Disease
  • Jaktinib Hydrochloride Tablets
  • Zhengzhou, Henan, China
    Henan Tumor Hospital
Nov 29, 2021

Acute-graft-versus-host Disease Trial (ASC930)

Not yet recruiting
  • Acute-graft-versus-host Disease
  • ASC930
  • (no location specified)
Nov 16, 2021

Acute GVHD in Intestine, Steroid Refractory GVHD Trial in France (MaaT013)

Available
  • Acute Graft Versus Host Disease in Intestine
  • Steroid Refractory GVHD
  • Amiens, France
  • +19 more
Jun 20, 2022

Steroid Resistant Acute GVHD Trial in Lyon (inolimomab)

Available
  • Steroid Resistant Acute Graft Versus Host Disease
  • inolimomab
  • Lyon, France
    ElsaLys Biotech
Sep 16, 2021

GVHD Trial in Germany, Spain, United States (Apraglutide)

Recruiting
  • GVHD
  • Stanford, California
  • +14 more
Nov 25, 2022

Steroid Refractory GVHD Trial in Taoyuan (Ruxolitinib)

Completed
  • Steroid Refractory GVHD
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital
Dec 15, 2022

Steroid-refractory Acute Graft-versus-host Disease Trial in Worldwide (MC0518, BAT)

Recruiting
  • Steroid-refractory Acute Graft-versus-host Disease
  • MC0518
  • BAT
  • Amiens, France
  • +37 more
Nov 1, 2022

GVHD Trial in Hackensack (Cyclophosphamide and Sirolimus, Low dose IL-2 with Cytoxan + Sirolimus, Low dose IL-2, low dose

Terminated
Has Results
  • Graft Versus Host Disease
  • Cyclophosphamide and Sirolimus
  • +3 more
  • Hackensack, New Jersey
    John Theurer Cancer Center at Hackensack University Medical Cent
Feb 4, 2022

Acute GVHD in Intestine, Steroid Refractory GVHD Trial in France, Germany, Spain (MaaT013)

Recruiting
  • Acute Graft Versus Host Disease in Intestine
  • Steroid Refractory GVHD
  • Amiens, France
  • +17 more
Jun 20, 2022

Acute GVHD Trial (MTX, Corticosteroid)

Not yet recruiting
  • Acute Graft Versus Host Disease
  • (no location specified)
Jun 26, 2023

Chronic GVHD, Acute GVHD, Steroid Refractory GVHD Trial in Leuven, Liège (Rapamycin, T regulatory cells)

Recruiting
  • Chronic Graft-Versus-Host Disease
  • +2 more
  • Leuven, Vlaams-Brabant, Belgium
  • +1 more
Apr 27, 2021

Steroid-Refractory Acute GVHD Trial in United States (T-Guard)

Terminated
Has Results
  • Steroid-Refractory Acute Graft Versus Host Disease
  • Duarte, California
  • +23 more
Dec 7, 2021

Graft-versus-host Disease (GVHD) Trial in United States (Ruxolitinib, Prednisone or methylprednisolone)

Completed
Has Results
  • Graft-versus-host Disease (GVHD)
  • Tucson, Arizona
  • +37 more
Oct 28, 2021

A PMS of Jakavi® in Steroid-Refractory Graft-versus-Host Disease

Not yet recruiting
  • Graft-versus-Host Disease
  • ruxolitinib
  • (no location specified)
Jan 11, 2023

Myelodysplastic/Myeloproliferative Tumor, Steroid Refractory GVHD, Allogeneic Hematopoietic Cell Transplant Trial in Toronto

Completed
  • Myelodysplastic/Myeloproliferative Neoplasm
  • +2 more
  • Decidual stromal cells (DSC)
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Graft-versus-host-disease, GVHD Trial in United States (Alpha 1-Antitrypsin)

Completed
Has Results
  • Graft-versus-host-disease
  • GVHD
  • Alpha 1-Antitrypsin
  • Duarte, California
  • +4 more
Jun 17, 2021

Chronic GVHD Trial in Duarte (biological, procedure, other)

Active, not recruiting
  • Chronic Graft Versus Host Disease
  • Aldesleukin
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023